BACKGROUND: Pancreatic carcinoma frequently infiltrates the portal vein or the superior mesenteric vein; pancreatectomy combined with portal vein/superior mesenteric vein resection represents a potentially curative treatment in these cases but is still a controversial procedure. METHODS: After performing a computerized Medline search, 12 series published during the last 8 years were selected, enrolling 399 patients who underwent pancreatectomy combined with portal vein/superior mesenteric vein resection for pancreatic carcinoma. Data were examined for information about indications, operation, adjuvant therapies, histopathology of resected specimens, perioperative results, and survival. Also, previous literature regarding the issue was extensively reviewed. RESULTS: Operative mortality and postoperative complication rates ranged from 0 to 7.7% and 16.7% to 54%, respectively. Median survival varied from 13 to 22 months; 5-year survival rate ranged from 9% to 18%. CONCLUSIONS: The current literature suggests that portal vein/superior mesenteric vein resection combined with pancreatectomy is a safe and feasible procedure that increases the number of patients who undergo curative resection and, therefore, provides important survival benefits to selected groups of patients. This procedure should always be considered in case of suspected tumor infiltration of portal/superior mesenteric vein to achieve clear resection margins, in the absence of other contraindications for resection.
BACKGROUND:Pancreatic carcinoma frequently infiltrates the portal vein or the superior mesenteric vein; pancreatectomy combined with portal vein/superior mesenteric vein resection represents a potentially curative treatment in these cases but is still a controversial procedure. METHODS: After performing a computerized Medline search, 12 series published during the last 8 years were selected, enrolling 399 patients who underwent pancreatectomy combined with portal vein/superior mesenteric vein resection for pancreatic carcinoma. Data were examined for information about indications, operation, adjuvant therapies, histopathology of resected specimens, perioperative results, and survival. Also, previous literature regarding the issue was extensively reviewed. RESULTS: Operative mortality and postoperative complication rates ranged from 0 to 7.7% and 16.7% to 54%, respectively. Median survival varied from 13 to 22 months; 5-year survival rate ranged from 9% to 18%. CONCLUSIONS: The current literature suggests that portal vein/superior mesenteric vein resection combined with pancreatectomy is a safe and feasible procedure that increases the number of patients who undergo curative resection and, therefore, provides important survival benefits to selected groups of patients. This procedure should always be considered in case of suspected tumor infiltration of portal/superior mesenteric vein to achieve clear resection margins, in the absence of other contraindications for resection.
Authors: Irene Epelboym; J DiNorcia; M Winner; M K Lee; J A Lee; B A Schrope; J A Chabot; J D Allendorf Journal: World J Surg Date: 2014-05 Impact factor: 3.352
Authors: Sara L Zettervall; Tammy Ju; Jeremy L Holzmacher; Bridget Huysman; Gregor Werba; Anton Sidawy; Paul Lin; Khashayar Vaziri Journal: J Gastrointest Surg Date: 2019-04-03 Impact factor: 3.452
Authors: Charbel Sandroussi; Chantelle Brace; Erin D Kennedy; Nancy N Baxter; Steven Gallinger; Alice C Wei Journal: J Gastrointest Surg Date: 2010-06-23 Impact factor: 3.452
Authors: Jiansheng Wang; Jeannelyn S Estrella; Lan Peng; Asif Rashid; Gauri R Varadhachary; Hua Wang; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Matthew H Katz; Henry F Gomez; Douglas B Evans; James L Abbruzzese; Jason B Fleming; Huamin Wang Journal: Cancer Date: 2011-12-16 Impact factor: 6.860